Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
General Internal Medicine
•
Infectious Disease
•
Neurology
•
Neuromuscular
Do patients on eculizumab or ravulizumab require repeat vaccination against meningococcal infection after a certain interval?
Answer from: at Academic Institution
Yes, CDC recommends a booster Men B vaccine 1 year after completion of series and then every 2-3 years thereafter, and booster Men C every 5 years.
Sign In
or
Register
to read more
16983
Related Questions
What leads you to suspect that a foot drop is secondary to a myopathy rather than a neuropathic process?
How do you counsel patients and doctors on antibiotic avoidance in myasthenia gravis?
How can I incorporate neuromuscular ultrasound into my practice with limited prior experience?
What types of cardiac conduction abnormalities would lead you to avoid using tricyclic antidepressants?
How do you typically manage a patient with a single positive blood culture from two sets growing Candida species in a stable patient without prosthetic devices or material?
How long do you treat Staphylococcus aureus pyomyositis with antibiotics?
What is your clinical threshold for treating a potential monoclonal gammopathy of thrombotic significance?
Are there any contraindications using nurtec in patients with headaches in the setting of recent RCVS?
In light of recent measles outbreaks, have you adjusted your vaccination counseling or preventive strategies for adult immunocompromised patients?
How do you evaluate for an ascending UTI in a patient with a urostomy?